Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.

Discover the latest employee benefits trends for 2025, from flexible work options to mental health support.

Stephen Stanko, a South Carolina death row inmate, chose lethal injection after a firing squad execution was criticized as "botched" and raised concerns about execution methods.

A newer trend in Botox and fillers is gaining popularity for its dual benefits, addressing both cosmetic concerns and medical conditions.

The public benefits charge has drawn the public's ire due to the debate over CT's electric prices, which are among the highest in the nation.

MIT says that due to concerns about the “integrity” of a high-profile paper on how artificial intelligence affects research and innovation, the paper ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

Injectable ART is administered to the gluteal muscle by a healthcare professional. Research might increase accessibility with self-injection, including into the thigh.

Are you eligible for 12 more months of GI Bill benefits from the Department of Veterans Affairs? Here's who qualifies and how to apply.